ReShape Lifesciences Inc reports results for the quarter ended in September - Earnings Summary

Vyome Holdings

11/11/2021 14:32

* ReShape Lifesciences Inc  RSLS.OQ  reported a quarterly
adjusted loss of $1.48​​ per share for the quarter ended in
September. The mean expectation of two analysts for the quarter
was for a loss of 15 cents per share.
* Revenue rose 8,327.3% to $3.71 million from a year ago; 
analysts expected $3.87 million. 
* ReShape Lifesciences Inc's reported EPS for the quarter was a
loss of $1.48​.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* ReShape Lifesciences Inc shares had fallen by 12.2% this
quarter and lost 43.8% so far this year.
* The company reported a quarterly loss of $17.7 million.
* Wall Street's median 12-month price target for ReShape
Lifesciences Inc is $9.13 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 02:32 p.m.
 ​All figures in US dollars unless otherwise stated